Distinct DNA methylomes of newborns and centenarians H Heyn, N Li, HJ Ferreira, S Moran, DG Pisano, A Gomez, J Diez, ... Proceedings of the National Academy of Sciences 109 (26), 10522-10527, 2012 | 813 | 2012 |
Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies RG Urdinguio, JV Sanchez-Mut, M Esteller The Lancet Neurology 8 (11), 1056-1072, 2009 | 675 | 2009 |
A DNA methylation fingerprint of 1628 human samples AF Fernandez, Y Assenov, JI Martin-Subero, B Balint, R Siebert, ... Genome research 22 (2), 407-419, 2012 | 427 | 2012 |
Genome-wide parent-of-origin DNA methylation analysis reveals the intricacies of human imprinting and suggests a germline methylation-independent mechanism of establishment C Tayama, V Romanelli, A Martin-Trujillo, I Iglesias-Platas, K Okamura, ... Genome research 24 (4), 554-569, 2014 | 257 | 2014 |
Epigenomic analysis detects aberrant super-enhancer DNA methylation in human cancer H Heyn, E Vidal, HJ Ferreira, M Vizoso, S Sayols, A Gomez, S Moran, ... Genome biology 17, 1-16, 2016 | 195 | 2016 |
Epigenetic alterations in Alzheimer’s disease JV Sanchez-Mut, J Gräff Frontiers in behavioral neuroscience 9, 347, 2015 | 163 | 2015 |
Human DNA methylomes of neurodegenerative diseases show common epigenomic patterns JV Sanchez-Mut, H Heyn, E Vidal, S Moran, S Sayols, R Delgado-Morales, ... Translational psychiatry 6 (1), e718-e718, 2016 | 150 | 2016 |
DNA methylation map of mouse and human brain identifies target genes in Alzheimer’s disease JV Sanchez-Mut, E Aso, N Panayotis, I Lott, M Dierssen, A Rabano, ... Brain 136 (10), 3018-3027, 2013 | 141 | 2013 |
Homocysteine and cognitive impairment in Parkinson's disease: a biochemical, neuroimaging, and genetic study MC Rodriguez‐Oroz, PM Lage, J Sanchez‐Mut, I Lamet, ... Movement disorders: official journal of the Movement Disorder Society 24 (10 …, 2009 | 109 | 2009 |
Promoter hypermethylation of the phosphatase DUSP22 mediates PKA-dependent TAU phosphorylation and CREB activation in Alzheimer's disease EM Sanchez-Mut JV, Aso E, Heyn H, Matsuda T, Bock C Hippocampus, 2014 | 108 | 2014 |
Parkinson's disease due to the R1441G mutation in Dardarin: a founder effect in the Basques J Simón‐Sánchez, JF Martí‐Massó, JV Sánchez‐Mut, C Paisán‐Ruiz, ... Movement disorders: official journal of the Movement Disorder Society 21 (11 …, 2006 | 108 | 2006 |
Linkage of DNA methylation quantitative trait loci to human cancer risk H Heyn, S Sayols, C Moutinho, E Vidal, JV Sanchez-Mut, OA Stefansson, ... Cell reports 7 (2), 331-338, 2014 | 94 | 2014 |
Whole-genome bisulfite DNA sequencing of a DNMT3B mutant patient H Heyn, E Vidal, S Sayols, JV Sanchez-Mut, S Moran, I Medina, ... Epigenetics 7 (6), 542-550, 2012 | 79 | 2012 |
A comprehensive DNA methylation profile of epithelial-to-mesenchymal transition FJ Carmona, V Davalos, E Vidal, A Gomez, H Heyn, Y Hashimoto, ... Cancer research 74 (19), 5608-5619, 2014 | 74 | 2014 |
PM20D1 is a quantitative trait locus associated with Alzheimer’s disease JV Sanchez-Mut, H Heyn, BA Silva, L Dixsaut, P Garcia-Esparcia, E Vidal, ... Nature medicine 24 (5), 598-603, 2018 | 71 | 2018 |
Mutations in JMJD1C are involved in Rett syndrome and intellectual disability MA Sáez, J Fernández-Rodríguez, C Moutinho, JV Sanchez-Mut, ... Genetics in Medicine 18 (4), 378-385, 2016 | 47 | 2016 |
Phylogenetic and in silico structural analysis of the Parkinson disease‐related kinase PINK1 F Cardona, JV Sánchez‐Mut, H Dopazo, J Pérez‐Tur Human mutation 32 (4), 369-378, 2011 | 45 | 2011 |
MeCP2-E1 isoform is a dynamically expressed, weakly DNA-bound protein with different protein and DNA interactions compared to MeCP2-E2 A Martínez de Paz, L Khajavi, H Martin, R Claveria-Gimeno, S Tom Dieck, ... Epigenetics & chromatin 12, 1-16, 2019 | 42 | 2019 |
Epigenetics in schizophrenia: a pilot study of global DNA methylation in different brain regions associated with higher cognitive functions R Alelú-Paz, FJ Carmona, JV Sanchez-Mut, A Cariaga-Martínez, ... Frontiers in psychology 7, 1496, 2016 | 40 | 2016 |
Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition F Mateo, EJ Arenas, H Aguilar, J Serra-Musach, GR De Garibay, J Boni, ... Oncogene 36 (19), 2737-2749, 2017 | 39 | 2017 |